| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/12/2003 | EP1003724B1 Substituted quinoline derivatives with antiviral action |
| 02/12/2003 | EP0937078B1 Tricyclic carbapenem compounds |
| 02/12/2003 | EP0934073B1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition |
| 02/12/2003 | EP0889690B1 Antibiotic cocktail and method of use |
| 02/12/2003 | EP0868424B1 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
| 02/12/2003 | EP0865447B1 Cyclic dodecapeptide and process for the preparation thereof |
| 02/12/2003 | EP0828488B1 Isothiazolones |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | EP0730459B1 The use of an ester of inositoltrisphosphate for the preparing of medicaments |
| 02/12/2003 | CN1396929A Cyclic compound |
| 02/12/2003 | CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396834A Stabilised pharmaceutical compositions and process for their preparation comprising antibiobic and expectorant |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396179A Anti fungal polypeptide extracted from eucommia bark and its extracting process |
| 02/12/2003 | CN1396178A Engineered polypeptide resisting infection of coated virus (hepatitis B virus) and its preparing process |
| 02/12/2003 | CN1396176A Method for purifying drug active protein by cation exchange chromatogrphy |
| 02/12/2003 | CN1396170A Crystal form of Pifuadefuwei |
| 02/12/2003 | CN1396164A Rusuan Jiatishaxing and its usage |
| 02/12/2003 | CN1396155A Garlicin extracted reversely by supercritical CO2 and process for preparing its injection |
| 02/12/2003 | CN1395970A Bacterial medical nano suppository for woman and its preparing process |
| 02/12/2003 | CN1395969A Leptospiral DNA vaccine |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395963A Composite medicine for disinfecting and relieving inflammation |
| 02/12/2003 | CN1395958A Medicine 'Yiganjiangmeisan' for treating hepatitis B and its preparing process |
| 02/12/2003 | CN1395949A Process for preparing medicine to treat pepatitis |
| 02/12/2003 | CN1395947A Medicine for treating wind-heat type common cold and its preparing process |
| 02/12/2003 | CN1395939A Compound of solanesol and its preparing process |
| 02/12/2003 | CN1395921A Application of torreyaester in resisting HIV |
| 02/12/2003 | CN1395920A Medicine for treating tinear manuum and tinear pedis |
| 02/12/2003 | CN1101404C Anti Bacillus pyocyaneu vitelline immunoglobulin products and use thereof |
| 02/12/2003 | CN1101226C 疫苗 Vaccine |
| 02/12/2003 | CN1101225C 乙肝疫苗 Hepatitis B vaccine |
| 02/12/2003 | CN1101212C Medicine-egg mixture for treating hepatitis B |
| 02/12/2003 | CN1101190C HIV protease inhibitor combination medicine |
| 02/12/2003 | CN1101189C Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as active ingredient |
| 02/11/2003 | US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines. |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518317 Antiviral agents |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518293 Anti-HIV imidazolone derivatives |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518285 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518276 Treating a p38 mediated disorders |
| 02/11/2003 | US6518270 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | US6518263 Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 02/11/2003 | US6518253 Treatment of viral infections using the L-isomer of ribavirin |
| 02/11/2003 | US6518251 Macrolides |
| 02/11/2003 | US6518249 Oligosaccharide derivatives and process for producing the same |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518013 Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission |
| 02/11/2003 | US6517889 Eliminating or minimizing coating material located within openings; contacting with coating solution then running and rotating a thread through the lumen |
| 02/11/2003 | US6517854 Antimicrobial sanitizing lotion with skin protection properties |
| 02/11/2003 | US6517845 Detecting infection in a mammal; binding antibody to polypeptide consisting essentially of amino acid sequence 2 |
| 02/11/2003 | US6517827 Anionic polymers as toxin binders and antibacterial agent |
| 02/11/2003 | US6517826 Anionic polymers as toxin binders and antibacterial agents |
| 02/11/2003 | CA2162880C Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv |
| 02/11/2003 | CA2058386C Cell free marek's disease virus vaccine |
| 02/11/2003 | CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2003010317A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | WO2003010313A1 Novel diphtheria anatoxins and their use as carrier |
| 02/06/2003 | WO2003010301A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010297A1 Probiotic bifidobacterium strains |
| 02/06/2003 | WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/06/2003 | WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 02/06/2003 | WO2003010194A2 Meningococcus adhesins nada, app and orf 40 |
| 02/06/2003 | WO2003010192A2 An inducer of apoptosis |
| 02/06/2003 | WO2003010191A1 New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialis |
| 02/06/2003 | WO2003010188A1 Production of high molecular mass lectins |
| 02/06/2003 | WO2003010179A1 Process for the preparation of 2'-3'-dideoxy-2',3'-didehydro-nucleosides |
| 02/06/2003 | WO2003010170A1 An improved method for preparation of cefuroxime axetil |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003010138A2 Piperidine derivatives as antibacterial agents |
| 02/06/2003 | WO2003009877A1 Topical pharmaceutical formulation |
| 02/06/2003 | WO2003009869A1 Vaccines comprising aluminium adjuvants and histidine |
| 02/06/2003 | WO2003009868A1 Antigenic compositions |
| 02/06/2003 | WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/06/2003 | WO2003009859A1 Immunotherapy for humans |
| 02/06/2003 | WO2003009855A2 Organo-phosphorous compounds for activating gamma/delta t cells |
| 02/06/2003 | WO2003009843A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 02/06/2003 | WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | WO2003009838A1 Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus |
| 02/06/2003 | WO2003009836A2 New uses for 2-amino-2-propane-1,3-diols |
| 02/06/2003 | WO2003009830A1 Coated granules of allylamine- or benzylamine-anti-mycotics |
| 02/06/2003 | WO2003009812A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/06/2003 | WO2003009802A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 02/06/2003 | WO2003009800A1 Sustained-release therapeutic bioadhesive systems |
| 02/06/2003 | WO2003009784A1 Ophthalmic drug delivery device |